|
1
|
Boceprevir for untreated chronic HCV genotype 1 infection.
|
N Engl J Med
|
2011
|
19.01
|
|
2
|
Telaprevir for previously treated chronic HCV infection.
|
N Engl J Med
|
2010
|
8.33
|
|
3
|
Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis.
|
JAMA
|
2012
|
7.62
|
|
4
|
Early virologic response to treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C.
|
Hepatology
|
2003
|
5.40
|
|
5
|
A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4(+)CD25(+)Foxp3(+) T cells.
|
Gastroenterology
|
2008
|
4.23
|
|
6
|
Sustained virologic response and clinical outcomes in patients with chronic hepatitis C and advanced fibrosis.
|
Ann Intern Med
|
2007
|
3.72
|
|
7
|
Early monotherapy with pegylated interferon alpha-2b for acute hepatitis C infection: the HEP-NET acute-HCV-II study.
|
Hepatology
|
2006
|
3.18
|
|
8
|
Hepatocyte telomere shortening and senescence are general markers of human liver cirrhosis.
|
FASEB J
|
2002
|
2.96
|
|
9
|
Increased risk of hepatocellular carcinoma among patients with hepatitis C cirrhosis and diabetes mellitus.
|
Hepatology
|
2008
|
2.80
|
|
10
|
Increased populations of regulatory T cells in peripheral blood of patients with hepatocellular carcinoma.
|
Cancer Res
|
2005
|
2.78
|
|
11
|
Peginterferon plus adefovir versus either drug alone for hepatitis delta.
|
N Engl J Med
|
2011
|
2.72
|
|
12
|
Interleukin 6/gp130-dependent pathways are protective during chronic liver diseases.
|
Hepatology
|
2003
|
2.68
|
|
13
|
Autoimmune acute liver failure: proposed clinical and histological criteria.
|
Hepatology
|
2011
|
2.64
|
|
14
|
Hepatitis B surface antigen (HBsAg) levels in the natural history of hepatitis B virus (HBV)-infection: a European perspective.
|
J Hepatol
|
2010
|
2.58
|
|
15
|
Humanized mice for modeling human infectious disease: challenges, progress, and outlook.
|
Cell Host Microbe
|
2009
|
2.58
|
|
16
|
Myeloid-derived suppressor cells in inflammatory bowel disease: a new immunoregulatory pathway.
|
Gastroenterology
|
2008
|
2.56
|
|
17
|
Prospective biopsy-controlled evaluation of cell death biomarkers for prediction of liver fibrosis and nonalcoholic steatohepatitis.
|
Hepatology
|
2011
|
2.49
|
|
18
|
Myeloid derived suppressor cells inhibit natural killer cells in patients with hepatocellular carcinoma via the NKp30 receptor.
|
Hepatology
|
2009
|
2.45
|
|
19
|
Myeloid derived suppressor cells in human diseases.
|
Int Immunopharmacol
|
2011
|
2.43
|
|
20
|
Validation of treatment strategies for enterohaemorrhagic Escherichia coli O104:H4 induced haemolytic uraemic syndrome: case-control study.
|
BMJ
|
2012
|
2.32
|
|
21
|
MicroRNAs play a role in spontaneous recovery from acute liver failure.
|
Hepatology
|
2014
|
2.23
|
|
22
|
Deletion of IKK2 in hepatocytes does not sensitize these cells to TNF-induced apoptosis but protects from ischemia/reperfusion injury.
|
J Clin Invest
|
2005
|
2.20
|
|
23
|
Genetic predisposition and environmental danger signals initiate chronic autoimmune hepatitis driven by CD4+ T cells.
|
Hepatology
|
2013
|
2.12
|
|
24
|
Argyrin a reveals a critical role for the tumor suppressor protein p27(kip1) in mediating antitumor activities in response to proteasome inhibition.
|
Cancer Cell
|
2008
|
2.12
|
|
25
|
Microbiologic analysis of peri-pancreatic fluid collected during EUS in patients with pancreatitis: impact on antibiotic therapy.
|
Gastrointest Endosc
|
2013
|
2.10
|
|
26
|
Endoscopic vacuum-assisted closure of upper intestinal anastomotic leaks.
|
Gastrointest Endosc
|
2008
|
2.06
|
|
27
|
Outcome and quality of life in patients with polycystic liver disease after liver or combined liver-kidney transplantation.
|
Liver Transpl
|
2006
|
2.04
|
|
28
|
Therapeutic vaccination of chronic hepatitis C nonresponder patients with the peptide vaccine IC41.
|
Gastroenterology
|
2008
|
2.03
|
|
29
|
Multicentric evaluation of model for end-stage liver disease-based allocation and survival after liver transplantation in Germany--limitations of the 'sickest first'-concept.
|
Transpl Int
|
2010
|
1.99
|
|
30
|
The SCF-FBXW5 E3-ubiquitin ligase is regulated by PLK4 and targets HsSAS-6 to control centrosome duplication.
|
Nat Cell Biol
|
2011
|
1.99
|
|
31
|
Increased hepatotoxicity of tumor necrosis factor-related apoptosis-inducing ligand in diseased human liver.
|
Hepatology
|
2007
|
1.97
|
|
32
|
The protease inhibitor, GS-9256, and non-nucleoside polymerase inhibitor tegobuvir alone, with ribavirin, or pegylated interferon plus ribavirin in hepatitis C.
|
Hepatology
|
2012
|
1.97
|
|
33
|
Hepatitis E virus (HEV)-specific T-cell responses are associated with control of HEV infection.
|
Hepatology
|
2012
|
1.94
|
|
34
|
The challenges in primary sclerosing cholangitis--aetiopathogenesis, autoimmunity, management and malignancy.
|
J Hepatol
|
2008
|
1.92
|
|
35
|
Eligibility and safety of triple therapy for hepatitis C: lessons learned from the first experience in a real world setting.
|
PLoS One
|
2013
|
1.89
|
|
36
|
Management of major postsurgical gastroesophageal intrathoracic leaks with an endoscopic vacuum-assisted closure system.
|
Gastrointest Endosc
|
2009
|
1.89
|
|
37
|
Skp2-dependent degradation of p27kip1 is essential for cell cycle progression.
|
Genes Dev
|
2004
|
1.88
|
|
38
|
A Direct in vivo RNAi screen identifies MKK4 as a key regulator of liver regeneration.
|
Cell
|
2013
|
1.86
|
|
39
|
Interferon-alpha-induced TRAIL on natural killer cells is associated with control of hepatitis C virus infection.
|
Gastroenterology
|
2010
|
1.85
|
|
40
|
Hepatic gas gangrene following liver transplantation.
|
Liver Transpl
|
2007
|
1.85
|
|
41
|
Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis.
|
Nat Genet
|
2013
|
1.83
|
|
42
|
Overlap syndromes: the International Autoimmune Hepatitis Group (IAIHG) position statement on a controversial issue.
|
J Hepatol
|
2010
|
1.80
|
|
43
|
Regulation of accumulation and function of myeloid derived suppressor cells in different murine models of hepatocellular carcinoma.
|
J Hepatol
|
2013
|
1.80
|
|
44
|
The introduction of MELD-based organ allocation impacts 3-month survival after liver transplantation by influencing pretransplant patient characteristics.
|
Transpl Int
|
2009
|
1.78
|
|
45
|
Breaking tolerance to the natural human liver autoantigen cytochrome P450 2D6 by virus infection.
|
J Exp Med
|
2008
|
1.76
|
|
46
|
Hepatitis C virus infection affects the brain-evidence from psychometric studies and magnetic resonance spectroscopy.
|
J Hepatol
|
2004
|
1.76
|
|
47
|
Apoptosis of regulatory T lymphocytes is increased in chronic inflammatory bowel disease and reversed by anti-TNFα treatment.
|
Gut
|
2011
|
1.75
|
|
48
|
Coffee induces expression of glucuronosyltransferases by the aryl hydrocarbon receptor and Nrf2 in liver and stomach.
|
Gastroenterology
|
2010
|
1.75
|
|
49
|
Antigen-specific FoxP3-transduced T-cells can control established type 1 diabetes.
|
Diabetes
|
2004
|
1.73
|
|
50
|
Glucocorticosteroids increase cell entry by hepatitis C virus.
|
Gastroenterology
|
2010
|
1.70
|
|
51
|
Genome-wide association analysis in primary sclerosing cholangitis.
|
Gastroenterology
|
2009
|
1.69
|
|
52
|
Prevalence and clinical associations of 10 defined autoantibodies in autoimmune polyendocrine syndrome type I.
|
J Clin Endocrinol Metab
|
2004
|
1.68
|
|
53
|
Hepatitis D virus infection--not a vanishing disease in Europe!
|
Hepatology
|
2007
|
1.68
|
|
54
|
Plasticity of human Th17 cells and iTregs is orchestrated by different subsets of myeloid cells.
|
Blood
|
2011
|
1.67
|
|
55
|
Telomerase gene mutations are associated with cirrhosis formation.
|
Hepatology
|
2011
|
1.67
|
|
56
|
The HEP-NET B/C co-infection trial: A prospective multicenter study to investigate the efficacy of pegylated interferon-alpha2b and ribavirin in patients with HBV/HCV co-infection.
|
J Hepatol
|
2008
|
1.65
|
|
57
|
Proteins induced by telomere dysfunction and DNA damage represent biomarkers of human aging and disease.
|
Proc Natl Acad Sci U S A
|
2008
|
1.65
|
|
58
|
The IL-6-gp130-STAT3 pathway in hepatocytes triggers liver protection in T cell-mediated liver injury.
|
J Clin Invest
|
2005
|
1.63
|
|
59
|
Activity of the mTOR inhibitor RAD001, the dual mTOR and PI3-kinase inhibitor BEZ235 and the PI3-kinase inhibitor BKM120 in hepatocellular carcinoma.
|
Liver Int
|
2013
|
1.60
|
|
60
|
Prognostic implications of lactate, bilirubin, and etiology in German patients with acute liver failure.
|
Clin Gastroenterol Hepatol
|
2008
|
1.59
|
|
61
|
Advances in the diagnosis, pathogenesis, and management of autoimmune hepatitis.
|
Gastroenterology
|
2010
|
1.58
|
|
62
|
Delayed versus immediate treatment for patients with acute hepatitis C: a randomised controlled non-inferiority trial.
|
Lancet Infect Dis
|
2013
|
1.58
|
|
63
|
Boceprevir, an NS3 serine protease inhibitor of hepatitis C virus, for the treatment of HCV infection.
|
Curr Opin Investig Drugs
|
2009
|
1.57
|
|
64
|
CD49d is a new marker for distinct myeloid-derived suppressor cell subpopulations in mice.
|
J Immunol
|
2010
|
1.57
|
|
65
|
Liver autoimmune serology: a consensus statement from the committee for autoimmune serology of the International Autoimmune Hepatitis Group.
|
J Hepatol
|
2004
|
1.57
|
|
66
|
Family 1 uridine-5'-diphosphate glucuronosyltransferases (UGT1A): from Gilbert's syndrome to genetic organization and variability.
|
Arch Toxicol
|
2008
|
1.56
|
|
67
|
Epidemiology, pathogenesis and management of hepatitis D: update and challenges ahead.
|
Nat Rev Gastroenterol Hepatol
|
2010
|
1.56
|
|
68
|
Clinical pharmacokinetics of everolimus.
|
Clin Pharmacokinet
|
2004
|
1.56
|
|
69
|
Pathogenesis and treatment of hepatitis e virus infection.
|
Gastroenterology
|
2012
|
1.55
|
|
70
|
Kinetics of hepatitis B surface antigen decline during 3 years of telbivudine treatment in hepatitis B e antigen-positive patients.
|
Hepatology
|
2010
|
1.55
|
|
71
|
Hepatic lentiviral gene transfer is associated with clonal selection, but not with tumor formation in serially transplanted rodents.
|
Hepatology
|
2013
|
1.55
|
|
72
|
Cytochrome P450 2A6: a new hepatic autoantigen in patients with chronic hepatitis C virus infection.
|
J Hepatol
|
2003
|
1.53
|
|
73
|
The green tea polyphenol, epigallocatechin-3-gallate, inhibits hepatitis C virus entry.
|
Hepatology
|
2011
|
1.52
|
|
74
|
[Prevalence of circulating autoantibodies in healthy individuals].
|
Med Klin (Munich)
|
2002
|
1.52
|
|
75
|
Silencing of caspase-8 in murine hepatocellular carcinomas is mediated via methylation of an essential promoter element.
|
Gastroenterology
|
2005
|
1.51
|
|
76
|
α-1-antitrypsin inhibits acute liver failure in mice.
|
Hepatology
|
2014
|
1.49
|
|
77
|
Angiopoietin-2 in acute liver failure.
|
Crit Care Med
|
2012
|
1.48
|
|
78
|
Antibody to hepatitis B surface antigen trough levels and half-lives do not differ after intravenous and intramuscular hepatitis B immunoglobulin administration after liver transplantation.
|
Liver Transpl
|
2008
|
1.48
|
|
79
|
Budesonide versus prednisone with azathioprine for the treatment of autoimmune hepatitis in children and adolescents.
|
J Pediatr
|
2013
|
1.47
|
|
80
|
MicroRNAs in the bile of patients with biliary strictures after liver transplantation.
|
Liver Transpl
|
2014
|
1.46
|
|
81
|
Nuclear factor-eythroid 2-related factor 2 prevents alcohol-induced fulminant liver injury.
|
Gastroenterology
|
2008
|
1.46
|
|
82
|
Duration of fecal shedding of Shiga toxin-producing Escherichia coli O104:H4 in patients infected during the 2011 outbreak in Germany: a multicenter study.
|
Clin Infect Dis
|
2013
|
1.46
|
|
83
|
Hepatitis in 2010: the dawn of a new era in HCV therapy.
|
Nat Rev Gastroenterol Hepatol
|
2011
|
1.45
|
|
84
|
Genome-wide association analysis in primary sclerosing cholangitis identifies two non-HLA susceptibility loci.
|
Nat Genet
|
2010
|
1.43
|
|
85
|
Endoscopic management of pancreatic pseudocysts or abscesses after an EUS-guided 1-step procedure for initial access.
|
Gastrointest Endosc
|
2006
|
1.43
|
|
86
|
Interleukin-6/glycoprotein 130-dependent pathways are protective during liver regeneration.
|
J Biol Chem
|
2002
|
1.42
|
|
87
|
UDP glucuronosyltransferase (UGT1A7) gene polymorphisms increase the risk of chronic pancreatitis and pancreatic cancer.
|
Gastroenterology
|
2003
|
1.42
|
|
88
|
Spontaneous tumor-specific humoral and cellular immune responses to NY-ESO-1 in hepatocellular carcinoma.
|
Clin Cancer Res
|
2004
|
1.42
|
|
89
|
Gilbert's disease and atazanavir: from phenotype to UDP-glucuronosyltransferase haplotype.
|
Hepatology
|
2006
|
1.41
|
|
90
|
Cyclosporine A inhibits hepatitis C virus nonstructural protein 2 through cyclophilin A.
|
Hepatology
|
2009
|
1.40
|
|
91
|
A pocket guide to identify patients at risk for chronic kidney disease after liver transplantation.
|
Transpl Int
|
2015
|
1.39
|
|
92
|
Low-dose cyclophosphamide treatment impairs regulatory T cells and unmasks AFP-specific CD4+ T-cell responses in patients with advanced HCC.
|
J Immunother
|
2010
|
1.38
|
|
93
|
Management of hepatitis C virus genotype 4: recommendations of an international expert panel.
|
J Hepatol
|
2010
|
1.38
|
|
94
|
Characterization, outcome, and prognosis in 273 patients with primary sclerosing cholangitis: A single center study.
|
Am J Gastroenterol
|
2006
|
1.36
|
|
95
|
C-terminal phosphorylation controls the stability and function of p27kip1.
|
EMBO J
|
2006
|
1.35
|
|
96
|
MicroRNA-221 overexpression accelerates hepatocyte proliferation during liver regeneration.
|
Hepatology
|
2013
|
1.32
|
|
97
|
Apoptotic, but not necrotic, tumor cell vaccines induce a potent immune response in vivo.
|
Int J Cancer
|
2003
|
1.32
|
|
98
|
Variation of hepatic glucuronidation: Novel functional polymorphisms of the UDP-glucuronosyltransferase UGT1A4.
|
Hepatology
|
2004
|
1.30
|
|
99
|
A critical role for notch signaling in the formation of cholangiocellular carcinomas.
|
Cancer Cell
|
2013
|
1.30
|
|
100
|
Hepatitis E in Germany--an under-reported infectious disease.
|
Dtsch Arztebl Int
|
2014
|
1.30
|
|
101
|
Food intake increases liver stiffness in patients with chronic or resolved hepatitis C virus infection.
|
Liver Int
|
2009
|
1.29
|
|
102
|
Extended analysis of a genome-wide association study in primary sclerosing cholangitis detects multiple novel risk loci.
|
J Hepatol
|
2012
|
1.29
|
|
103
|
The diagnosis and treatment of hepatocellular carcinoma.
|
Dtsch Arztebl Int
|
2014
|
1.29
|
|
104
|
Bile proteomic profiles differentiate cholangiocarcinoma from primary sclerosing cholangitis and choledocholithiasis.
|
Hepatology
|
2011
|
1.28
|
|
105
|
Treatment of chronic hepatitis C with PEGylated interferon and ribavirin.
|
Curr Gastroenterol Rep
|
2002
|
1.28
|
|
106
|
S100A9 a new marker for monocytic human myeloid-derived suppressor cells.
|
Immunology
|
2012
|
1.28
|
|
107
|
Ki67, E-cadherin, and p53 as prognostic indicators of long-term outcome after liver transplantation for metastatic neuroendocrine tumors.
|
Transplantation
|
2002
|
1.27
|
|
108
|
Clinical feasibility of liver elastography by acoustic radiation force impulse imaging (ARFI).
|
Dig Liver Dis
|
2011
|
1.27
|
|
109
|
Performance and clinical utility of a novel fully automated quantitative HCV-core antigen assay.
|
J Clin Virol
|
2009
|
1.26
|
|
110
|
Hepatitis E virus infection as a cause of graft hepatitis in liver transplant recipients.
|
Liver Transpl
|
2010
|
1.26
|
|
111
|
Increase in frequency of myeloid-derived suppressor cells in mice with spontaneous pancreatic carcinoma.
|
Immunology
|
2009
|
1.25
|
|
112
|
Inhibition of hepatitis C virus translation and subgenomic replication by siRNAs directed against highly conserved HCV sequence and cellular HCV cofactors.
|
J Hepatol
|
2005
|
1.24
|
|
113
|
Basal core promoter and precore mutations in the hepatitis B virus genome enhance replication efficacy of Lamivudine-resistant mutants.
|
J Virol
|
2004
|
1.24
|
|
114
|
Initial presentation of acute hepatitis C virus (HCV) infection among HIV-negative and HIV-positive individuals-experience from 2 large German networks on the study of acute HCV infection.
|
Clin Infect Dis
|
2009
|
1.23
|
|
115
|
Selection of hepatitis B virus polymerase mutants with enhanced replication by lamivudine treatment after liver transplantation.
|
Gastroenterology
|
2002
|
1.22
|
|
116
|
High adiponectin in chronic liver disease and cholestasis suggests biliary route of adiponectin excretion in vivo.
|
J Hepatol
|
2005
|
1.22
|
|
117
|
Inhibition of hepatitis B virus replication in vivo by nucleoside analogues and siRNA.
|
Gastroenterology
|
2003
|
1.22
|
|
118
|
How stable is the hepatitis C virus (HCV)? Environmental stability of HCV and its susceptibility to chemical biocides.
|
J Infect Dis
|
2010
|
1.21
|
|
119
|
Identification and expression analysis of the aldo-ketoreductase1-B10 gene in primary malignant liver tumours.
|
J Hepatol
|
2009
|
1.21
|
|
120
|
Caspase activation is associated with spontaneous recovery from acute liver failure.
|
Hepatology
|
2008
|
1.20
|
|
121
|
The Enhanced Liver Fibrosis (ELF) score: normal values, influence factors and proposed cut-off values.
|
J Hepatol
|
2013
|
1.20
|
|
122
|
Hepatocellular telomere shortening correlates with chromosomal instability and the development of human hepatoma.
|
Hepatology
|
2004
|
1.19
|
|
123
|
Investigation of SEN virus infection in patients with cryptogenic acute liver failure, hepatitis-associated aplastic anemia, or acute and chronic non-A-E hepatitis.
|
J Infect Dis
|
2003
|
1.18
|
|
124
|
Repopulation efficiencies of adult hepatocytes, fetal liver progenitor cells, and embryonic stem cell-derived hepatic cells in albumin-promoter-enhancer urokinase-type plasminogen activator mice.
|
Am J Pathol
|
2009
|
1.18
|
|
125
|
Routine bile collection for microbiological analysis during cholangiography and its impact on the management of cholangitis.
|
Gastrointest Endosc
|
2010
|
1.16
|
|
126
|
The cellular level of telomere dysfunction determines induction of senescence or apoptosis in vivo.
|
EMBO Rep
|
2005
|
1.16
|
|
127
|
A phase II open label trial evaluating safety and efficacy of a telomerase peptide vaccination in patients with advanced hepatocellular carcinoma.
|
BMC Cancer
|
2010
|
1.15
|
|
128
|
Genetic association of vitamin D receptor polymorphisms with primary biliary cirrhosis and autoimmune hepatitis.
|
Hepatology
|
2002
|
1.15
|
|
129
|
Ribavirin treatment of acute and chronic hepatitis E: a single-centre experience.
|
Liver Int
|
2013
|
1.14
|
|
130
|
Telomere length is reset during early mammalian embryogenesis.
|
Proc Natl Acad Sci U S A
|
2004
|
1.14
|
|
131
|
Liver transplantation improves hepatic myelopathy: evidence by three cases.
|
Gastroenterology
|
2003
|
1.14
|
|
132
|
Improvement of objective GERD parameters after radiofrequency energy delivery: a European study.
|
Scand J Gastroenterol
|
2007
|
1.13
|
|
133
|
Lack of gp130 expression in hepatocytes promotes liver injury.
|
Gastroenterology
|
2003
|
1.12
|
|
134
|
Testing the importance of p27 degradation by the SCFskp2 pathway in murine models of lung and colon cancer.
|
Proc Natl Acad Sci U S A
|
2006
|
1.12
|
|
135
|
Treatment options for hepatitis delta virus infection.
|
Curr Infect Dis Rep
|
2013
|
1.12
|
|
136
|
Elevated circulating adiponectin levels in liver cirrhosis are associated with reduced liver function and altered hepatic hemodynamics.
|
Am J Physiol Endocrinol Metab
|
2004
|
1.12
|
|
137
|
The human caspase-8 promoter sustains basal activity through SP1 and ETS-like transcription factors and can be up-regulated by a p53-dependent mechanism.
|
J Biol Chem
|
2003
|
1.12
|
|
138
|
High rate of spontaneous clearance of acute hepatitis C virus genotype 3 infection.
|
J Med Virol
|
2004
|
1.12
|
|
139
|
Urine proteomic analysis differentiates cholangiocarcinoma from primary sclerosing cholangitis and other benign biliary disorders.
|
Gut
|
2012
|
1.11
|
|
140
|
Genome-wide association analysis in primary sclerosing cholangitis and ulcerative colitis identifies risk loci at GPR35 and TCF4.
|
Hepatology
|
2013
|
1.11
|
|
141
|
The extent of liver steatosis in chronic hepatitis C virus infection is mirrored by caspase activity in serum.
|
Hepatology
|
2005
|
1.10
|
|
142
|
Gilbert's Syndrome and irinotecan toxicity: combination with UDP-glucuronosyltransferase 1A7 variants increases risk.
|
Cancer Epidemiol Biomarkers Prev
|
2008
|
1.10
|
|
143
|
Telomeres and telomerase: a dual role in hepatocarcinogenesis.
|
Hepatology
|
2004
|
1.10
|
|
144
|
C/EBP beta isoforms LIP and LAP modulate progression of the cell cycle in the regenerating mouse liver.
|
Hepatology
|
2004
|
1.10
|
|
145
|
Diagnostic potential of circulating TIMP-1 and MMP-2 as markers of liver fibrosis in patients with chronic hepatitis C.
|
Clin Chim Acta
|
2002
|
1.09
|
|
146
|
The cyclin E regulator cullin 3 prevents mouse hepatic progenitor cells from becoming tumor-initiating cells.
|
J Clin Invest
|
2010
|
1.07
|
|
147
|
Inhibition of hedgehog signaling attenuates carcinogenesis in vitro and increases necrosis of cholangiocellular carcinoma.
|
Hepatology
|
2013
|
1.07
|
|
148
|
Mutational characterization of the bile acid receptor TGR5 in primary sclerosing cholangitis.
|
PLoS One
|
2010
|
1.07
|
|
149
|
Antitumoral immune response by recruitment and expansion of dendritic cells in tumors infected with telomerase-dependent oncolytic viruses.
|
Cancer Res
|
2009
|
1.06
|
|
150
|
Treatment with daily consensus interferon (CIFN) plus ribavirin in non-responder patients with chronic hepatitis C: a randomized open-label pilot study.
|
J Hepatol
|
2005
|
1.06
|
|
151
|
Bone morphogenetic protein 7 is elevated in patients with chronic liver disease and exerts fibrogenic effects on human hepatic stellate cells.
|
Dig Dis Sci
|
2007
|
1.05
|
|
152
|
Multi-stage analysis of differential gene expression in BALB/C mouse liver development by high-density microarrays.
|
Differentiation
|
2003
|
1.05
|
|
153
|
Role of activator protein 1, nuclear factor-kappaB, and nuclear factor of activated T cells in IgE receptor-mediated cytokine expression in mature human mast cells.
|
J Allergy Clin Immunol
|
2003
|
1.04
|
|
154
|
Sodium and chloride absorptive defects in the small intestine in Slc26a6 null mice.
|
Pflugers Arch
|
2007
|
1.04
|
|
155
|
Telomerase antagonists GRN163 and GRN163L inhibit tumor growth and increase chemosensitivity of human hepatoma.
|
Hepatology
|
2005
|
1.04
|
|
156
|
Ghrelin in chronic liver disease.
|
J Hepatol
|
2003
|
1.04
|
|
157
|
Late HDV RNA relapse after peginterferon alpha-based therapy of chronic hepatitis delta.
|
Hepatology
|
2014
|
1.04
|
|
158
|
Strategies for managing anemia in hepatitis C patients undergoing antiviral therapy.
|
Am J Gastroenterol
|
2007
|
1.03
|
|
159
|
Acute liver failure: a life-threatening disease.
|
Dtsch Arztebl Int
|
2011
|
1.03
|
|
160
|
Anemia during treatment with peginterferon Alfa-2b/ribavirin and boceprevir: Analysis from the serine protease inhibitor therapy 2 (SPRINT-2) trial.
|
Hepatology
|
2013
|
1.03
|
|
161
|
Expression and coordinated regulation of matrix metalloproteinases in chronic hepatitis C and hepatitis C virus-induced liver cirrhosis.
|
Clin Sci (Lond)
|
2003
|
1.03
|
|
162
|
Managing HBV in patients with impaired immunity.
|
Gut
|
2010
|
1.02
|
|
163
|
Treatment challenges and investigational opportunities in autoimmune hepatitis.
|
Hepatology
|
2005
|
1.02
|
|
164
|
Etiologies and outcomes of acute liver failure in Germany.
|
Clin Gastroenterol Hepatol
|
2012
|
1.02
|
|
165
|
Arrest all accessories--inhibition of hepatitis C virus by compounds that target host factors.
|
Discov Med
|
2011
|
1.01
|
|
166
|
Virus-induced tumor inflammation facilitates effective DC cancer immunotherapy in a Treg-dependent manner in mice.
|
J Clin Invest
|
2011
|
1.01
|
|
167
|
MicroRNA-221 regulates FAS-induced fulminant liver failure.
|
Hepatology
|
2011
|
1.01
|
|
168
|
Viral kinetics in patients with chronic hepatitis C treated with the serine protease inhibitor BILN 2061.
|
Antivir Ther
|
2006
|
1.01
|
|
169
|
Murine embryonic stem cell-derived hepatic progenitor cells engraft in recipient livers with limited capacity of liver tissue formation.
|
Cell Transplant
|
2008
|
1.01
|
|
170
|
Famciclovir treatment of chronic delta hepatitis.
|
J Hepatol
|
2002
|
1.01
|
|
171
|
Autoantibodies and autoantigens in autoimmune hepatitis.
|
Semin Liver Dis
|
2002
|
1.01
|
|
172
|
Prediction of survival after liver transplantation by pre-transplant parameters.
|
Scand J Gastroenterol
|
2008
|
1.00
|
|
173
|
Jun kinase modulates tumor necrosis factor-dependent apoptosis in liver cells.
|
Hepatology
|
2002
|
1.00
|
|
174
|
Peptide-beta2-microglobulin-MHC fusion molecules bind antigen-specific T cells and can be used for multivalent MHC-Ig complexes.
|
J Immunol Methods
|
2002
|
1.00
|
|
175
|
Establishment of a novel quantitative hepatitis D virus (HDV) RNA assay using the Cobas TaqMan platform to study HDV RNA kinetics.
|
J Clin Microbiol
|
2010
|
1.00
|
|
176
|
Implementation of proteomic biomarkers: making it work.
|
Eur J Clin Invest
|
2012
|
1.00
|
|
177
|
Immunotherapy of HCC.
|
Rev Recent Clin Trials
|
2008
|
1.00
|
|
178
|
Antitumoural immunity by virus-mediated immunogenic apoptosis inhibits metastatic growth of hepatocellular carcinoma.
|
Gut
|
2010
|
1.00
|
|
179
|
Immunotherapy of hepatocellular carcinoma.
|
J Hepatol
|
2006
|
1.00
|
|
180
|
Whom? When? How? Another piece of evidence for early treatment of acute hepatitis C.
|
Hepatology
|
2004
|
0.98
|
|
181
|
Definition and management of anemia in patients infected with hepatitis C virus.
|
Liver Int
|
2006
|
0.98
|
|
182
|
Telomere shortening correlates with increasing aneuploidy of chromosome 8 in human hepatocellular carcinoma.
|
Hepatology
|
2005
|
0.98
|
|
183
|
Caspase activation is required for antiviral treatment response in chronic hepatitis C virus infection.
|
Hepatology
|
2006
|
0.98
|
|
184
|
A decline in hepatitis B virus surface antigen (hbsag) predicts clearance, but does not correlate with quantitative hbeag or HBV DNA levels.
|
Antivir Ther
|
2008
|
0.98
|
|
185
|
Correlation between the Elecsys HBsAg II assay and the Architect assay for the quantification of hepatitis B surface antigen (HBsAg) in the serum.
|
J Clin Virol
|
2011
|
0.97
|
|
186
|
Clearance of low levels of HCV viremia in the absence of a strong adaptive immune response.
|
Virol J
|
2007
|
0.97
|
|
187
|
Immune responses in hepatocellular carcinoma.
|
Dig Dis
|
2010
|
0.97
|
|
188
|
Influence of mutations in the hepatitis B virus genome on virus replication and drug resistance--implications for novel antiviral strategies.
|
Curr Med Chem
|
2004
|
0.97
|
|
189
|
Epithelial mesenchymal transition and pancreatic tumor initiating CD44+/EpCAM+ cells are inhibited by γ-secretase inhibitor IX.
|
PLoS One
|
2012
|
0.97
|
|
190
|
Therapeutic vaccine IC41 as late add-on to standard treatment in patients with chronic hepatitis C.
|
Vaccine
|
2009
|
0.97
|
|
191
|
Second-wave protease inhibitors: choosing an heir.
|
Clin Liver Dis
|
2011
|
0.96
|
|
192
|
Quantitative gene expression analysis reveals transition of fetal liver progenitor cells to mature hepatocytes after transplantation in uPA/RAG-2 mice.
|
Am J Pathol
|
2003
|
0.96
|
|
193
|
Failure of hepatitis B vaccination with conventional HBsAg vaccine in patients with continuous HBIG prophylaxis after liver transplantation.
|
Liver Transpl
|
2007
|
0.96
|
|
194
|
Epidemiological trends in incidence and mortality of hepatobiliary cancers in Germany.
|
Scand J Gastroenterol
|
2011
|
0.96
|
|
195
|
Quantitative HBsAg and HDV-RNA levels in chronic delta hepatitis.
|
Liver Int
|
2009
|
0.96
|
|
196
|
Interaction between oxidative stress sensor Nrf2 and xenobiotic-activated aryl hydrocarbon receptor in the regulation of the human phase II detoxifying UDP-glucuronosyltransferase 1A10.
|
J Biol Chem
|
2010
|
0.96
|
|
197
|
The genetic background of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy and its autoimmune disease components.
|
J Mol Med (Berl)
|
2002
|
0.95
|
|
198
|
Hepatic manifestation is associated with ALK1 in hereditary hemorrhagic telangiectasia: identification of five novel ALK1 and one novel ENG mutations.
|
Hum Mutat
|
2005
|
0.95
|
|
199
|
Prometheus--a new extracorporeal system for the treatment of liver failure.
|
J Hepatol
|
2003
|
0.95
|
|
200
|
Genetic variability of aryl hydrocarbon receptor (AhR)-mediated regulation of the human UDP glucuronosyltransferase (UGT) 1A4 gene.
|
Toxicol Appl Pharmacol
|
2008
|
0.95
|
|
201
|
The degree of liver injury determines the role of p21 in liver regeneration and hepatocarcinogenesis in mice.
|
Hepatology
|
2013
|
0.95
|
|
202
|
IL-4-induced priming of human intestinal mast cells for enhanced survival and Th2 cytokine generation is reversible and associated with increased activity of ERK1/2 and c-Fos.
|
J Immunol
|
2005
|
0.95
|
|
203
|
Anti-Gr-1 antibody depletion fails to eliminate hepatic myeloid-derived suppressor cells in tumor-bearing mice.
|
J Leukoc Biol
|
2012
|
0.95
|
|
204
|
Stem cells in liver regeneration and therapy.
|
Cell Tissue Res
|
2007
|
0.95
|
|
205
|
Acute hepatitis B virus infection by genotype F despite successful vaccination in an immune-competent German patient.
|
J Clin Virol
|
2007
|
0.94
|
|
206
|
Long-term outcome of liver transplantation for autoimmune hepatitis.
|
Clin Transplant
|
2004
|
0.94
|
|
207
|
Telomeres and telomerase: new targets for the treatment of liver cirrhosis and hepatocellular carcinoma.
|
J Hepatol
|
2004
|
0.94
|
|
208
|
Gene expression analysis identifies novel genes participating in early murine liver development and adult liver regeneration.
|
Differentiation
|
2006
|
0.94
|
|
209
|
Serum biomarkers of cell death for monitoring therapy response of gastrointestinal carcinomas.
|
Eur J Cancer
|
2010
|
0.94
|
|
210
|
Interferon α-stimulated natural killer cells from patients with acute hepatitis C virus (HCV) infection recognize HCV-infected and uninfected hepatoma cells via DNAX accessory molecule-1.
|
J Infect Dis
|
2012
|
0.94
|
|
211
|
Hepatitis B surface antigen (HBsAg) decrease and serum interferon-inducible protein-10 levels as predictive markers for HBsAg loss during treatment with nucleoside/nucleotide analogues.
|
Antivir Ther
|
2011
|
0.94
|
|
212
|
Elevation of Nepsilon-(carboxymethyl)lysine-modified advanced glycation end products in chronic liver disease is an indicator of liver cirrhosis.
|
Clin Biochem
|
2006
|
0.93
|
|
213
|
Grading of hypervascular hepatocellular carcinoma using late phase of contrast enhanced sonography - a prospective study.
|
Dig Liver Dis
|
2011
|
0.93
|
|
214
|
Genetically induced pancreatic adenocarcinoma is highly immunogenic and causes spontaneous tumor-specific immune responses.
|
Cancer Res
|
2006
|
0.93
|
|
215
|
Functional and phenotypic characterization of peptide-vaccine-induced HCV-specific CD8+ T cells in healthy individuals and chronic hepatitis C patients.
|
Vaccine
|
2007
|
0.93
|
|
216
|
Incidence and long-term risk of de novo malignancies after liver transplantation with implications for prevention and detection.
|
Liver Transpl
|
2013
|
0.92
|
|
217
|
Prevalence of HBV genotypes in Central and Eastern Europe.
|
J Med Virol
|
2008
|
0.92
|
|
218
|
Necrotic tumor cell death in vivo impairs tumor-specific immune responses.
|
J Immunol
|
2007
|
0.92
|
|
219
|
The role of stem cells in physiology, pathophysiology, and therapy of the liver.
|
Stem Cell Rev
|
2006
|
0.92
|
|
220
|
The BH3-only protein bid does not mediate death-receptor-induced liver injury in obstructive cholestasis.
|
Am J Pathol
|
2009
|
0.92
|
|
221
|
Large-scale isolation of human hepatocytes for therapeutic application.
|
Cell Transplant
|
2005
|
0.92
|
|
222
|
Review article: clinical experience with Prometheus.
|
Ther Apher Dial
|
2006
|
0.92
|
|
223
|
Quantitative gene expression profiling reveals a fetal hepatic phenotype of murine ES-derived hepatocytes.
|
Int J Dev Biol
|
2004
|
0.92
|
|
224
|
Reevaluation of bone marrow-derived cells as a source for hepatocyte regeneration.
|
Cell Transplant
|
2004
|
0.92
|
|
225
|
Mechanisms of secretion-associated shrinkage and volume recovery in cultured rabbit parietal cells.
|
Am J Physiol Gastrointest Liver Physiol
|
2006
|
0.91
|
|
226
|
Budesonide in previously untreated autoimmune hepatitis.
|
Liver Int
|
2005
|
0.91
|
|
227
|
Plasma levels of PBEF/Nampt/visfatin are decreased in patients with liver cirrhosis.
|
Am J Physiol Gastrointest Liver Physiol
|
2008
|
0.91
|
|
228
|
Gene expression profile at the G1/S transition of liver regeneration after partial hepatectomy in mice.
|
Cell Cycle
|
2004
|
0.91
|
|
229
|
Approaches to liver biopsy techniques--revisited.
|
Semin Liver Dis
|
2006
|
0.91
|
|
230
|
Clinical relevance of transjugular liver biopsy in comparison with percutaneous and laparoscopic liver biopsy.
|
Gastroenterol Res Pract
|
2009
|
0.91
|
|
231
|
Human intestinal fibroblasts prevent apoptosis in human intestinal mast cells by a mechanism independent of stem cell factor, IL-3, IL-4, and nerve growth factor.
|
J Immunol
|
2004
|
0.91
|
|
232
|
Chronic hepatitis E virus infection beyond transplantation or human immunodeficiency virus infection.
|
Hepatology
|
2014
|
0.91
|
|
233
|
HCV core antigen testing in HIV- and HBV-coinfected patients, and in HCV-infected patients on hemodialysis.
|
J Clin Virol
|
2011
|
0.90
|
|
234
|
FibroSURE and FibroScan in relation to treatment response in chronic hepatitis C virus.
|
World J Gastroenterol
|
2011
|
0.90
|
|
235
|
Influence of different frequencies and insertion depths on the diagnostic accuracy of liver elastography by acoustic radiation force impulse imaging (ARFI).
|
Eur J Radiol
|
2013
|
0.90
|
|
236
|
Transarterial chemoembolization using degradable starch microspheres and iodized oil in the treatment of advanced hepatocellular carcinoma: evaluation of tumor response, toxicity, and survival.
|
Hepatobiliary Pancreat Dis Int
|
2007
|
0.90
|
|
237
|
Ultrasonography in patients with Budd-Chiari syndrome: diagnostic signs and prognostic implications.
|
J Hepatol
|
2008
|
0.90
|
|
238
|
Hairpin ribozymes in combination with siRNAs against highly conserved hepatitis C virus sequence inhibit RNA replication and protein translation from hepatitis C virus subgenomic replicons.
|
FEBS J
|
2005
|
0.90
|
|
239
|
Hepatitis B virus immunization with an adjuvant containing vaccine after liver transplantation for hepatitis B-related disease: failure of humoral and cellular immune response.
|
Transpl Int
|
2006
|
0.90
|
|
240
|
Clinical relevance of autoantibodies after pediatric liver transplantation.
|
Clin Transplant
|
2007
|
0.90
|
|
241
|
Limited effectiveness and safety profile of protease inhibitor-based triple therapy against chronic hepatitis C in a real-world cohort with a high proportion of advanced liver disease.
|
Eur J Gastroenterol Hepatol
|
2014
|
0.90
|
|
242
|
Hepatic expression of A disintegrin and metalloproteinase (ADAM) and ADAMs with thrombospondin motives (ADAM-TS) enzymes in patients with chronic liver diseases.
|
J Hepatol
|
2008
|
0.89
|
|
243
|
Successful treatment of fibrosing cholestatic hepatitis using adefovir dipivoxil in a patient with cirrhosis and renal insufficiency.
|
Liver Transpl
|
2003
|
0.89
|
|
244
|
Clinical effectiveness and cost effectiveness of tailoring chronic hepatitis C treatment with peginterferon alpha-2b plus ribavirin to HCV genotype and early viral response: a decision analysis based on German guidelines.
|
Pharmacoeconomics
|
2009
|
0.89
|
|
245
|
Successful treatment of cervical esophageal leakage by endoscopic-vacuum assisted closure therapy.
|
World J Gastrointest Endosc
|
2013
|
0.89
|
|
246
|
Characterization and clinical course of hepatobiliary carcinoma in patients with primary sclerosing cholangitis.
|
Scand J Gastroenterol
|
2006
|
0.89
|
|
247
|
Anti-HDV immunoglobulin M testing in hepatitis delta revisited: correlations with disease activity and response to pegylated interferon-α2a treatment.
|
Antivir Ther
|
2011
|
0.89
|
|
248
|
Sonographic criteria for the diagnosis of hepatic involvement in hereditary hemorrhagic telangiectasia (HHT).
|
Hepatology
|
2003
|
0.89
|
|
249
|
Increased incidence of anti-LKM autoantibodies in a consecutive cohort of hepatitis C patients from central Greece.
|
Eur J Gastroenterol Hepatol
|
2002
|
0.89
|
|
250
|
HCV's days are numbered: next-generation direct-acting antivirals and host-targeting agents.
|
Antivir Ther
|
2012
|
0.88
|
|
251
|
Critical appraisal of clinical practice guidelines for diagnosis and treatment of hepatocellular carcinoma.
|
J Gastroenterol Hepatol
|
2011
|
0.88
|
|
252
|
Hepatocyte transplantation in an acute liver failure due to mushroom poisoning.
|
Transplantation
|
2006
|
0.88
|
|
253
|
Treatment of HBV/HCV coinfection.
|
Expert Opin Pharmacother
|
2010
|
0.88
|
|
254
|
Selectivity of oncolytic viral replication prevents antiviral immune response and toxicity, but does not improve antitumoral immunity.
|
Mol Ther
|
2010
|
0.88
|
|
255
|
Impact of intra- and interspecies variation of occludin on its function as coreceptor for authentic hepatitis C virus particles.
|
J Virol
|
2011
|
0.88
|
|
256
|
Epitope spreading of the anti-CYP2D6 antibody response in patients with autoimmune hepatitis and in the CYP2D6 mouse model.
|
J Autoimmun
|
2011
|
0.88
|
|
257
|
Microsphere priming facilitates induction of potent therapeutic T-cell immune responses against autochthonous liver cancers.
|
Eur J Immunol
|
2014
|
0.88
|
|
258
|
Relevance of hepatitis B core gene deletions in patients after kidney transplantation.
|
Gastroenterology
|
2003
|
0.87
|
|
259
|
Prospective analysis of German patients with hepatocellular carcinoma undergoing transcatheter arterial chemoembolization with or without prophylactic antibiotic therapy.
|
J Gastroenterol Hepatol
|
2005
|
0.87
|
|
260
|
Elevated resistin levels in cirrhosis are associated with the proinflammatory state and altered hepatic glucose metabolism but not with insulin resistance.
|
Am J Physiol Endocrinol Metab
|
2006
|
0.87
|
|
261
|
Decreased hepatic RBP4 secretion is correlated with reduced hepatic glucose production but is not associated with insulin resistance in patients with liver cirrhosis.
|
Clin Endocrinol (Oxf)
|
2008
|
0.87
|
|
262
|
Human CCR4+ CCR6+ Th17 cells suppress autologous CD8+ T cell responses.
|
J Immunol
|
2012
|
0.87
|
|
263
|
Pathology of flupirtine-induced liver injury: a histological and clinical study of six cases.
|
Virchows Arch
|
2011
|
0.87
|
|
264
|
Antral injections of botulinum a toxin for the treatment of obesity.
|
Ann Intern Med
|
2003
|
0.87
|
|
265
|
Donor origin of de novo hepatocellular carcinoma in hepatic allografts.
|
Transplantation
|
2003
|
0.87
|
|
266
|
GB virus C genotype determination in GB virus-C/HIV co-infected individuals.
|
J Med Virol
|
2003
|
0.86
|
|
267
|
Compromised function of natural killer cells in acute and chronic viral hepatitis.
|
J Infect Dis
|
2013
|
0.86
|
|
268
|
IFN-γ regulates survival and function of tumor-induced CD11b+ Gr-1high myeloid derived suppressor cells by modulating the anti-apoptotic molecule Bcl2a1.
|
Eur J Immunol
|
2014
|
0.86
|
|
269
|
Hepatitis D virus-specific cytokine responses in patients with chronic hepatitis delta before and during interferon alfa-treatment.
|
Liver Int
|
2011
|
0.86
|
|
270
|
Tolerability and efficacy of a low-volume enteral supplement containing key nutrients in the critically ill.
|
Clin Nutr
|
2011
|
0.86
|
|
271
|
Immunotherapy of hepatocellular carcinoma.
|
Expert Rev Gastroenterol Hepatol
|
2010
|
0.86
|
|
272
|
Regulation of the human bile acid UDP-glucuronosyltransferase 1A3 by the farnesoid X receptor and bile acids.
|
J Hepatol
|
2010
|
0.86
|
|
273
|
The strength of the Fas ligand signal determines whether hepatocytes act as type 1 or type 2 cells in murine livers.
|
Hepatology
|
2009
|
0.86
|
|
274
|
Secretagogue stimulation enhances NBCe1 (electrogenic Na(+)/HCO(3)(-) cotransporter) surface expression in murine colonic crypts.
|
Am J Physiol Gastrointest Liver Physiol
|
2009
|
0.86
|
|
275
|
Differential gene expression of NAD(P)H:quinone oxidoreductase and NRH:quinone oxidoreductase in human hepatocellular and biliary tissue.
|
Mol Pharmacol
|
2002
|
0.86
|
|
276
|
Regulatory effects of stem cell factor and interleukin-4 on adhesion of human mast cells to extracellular matrix proteins.
|
Blood
|
2002
|
0.86
|
|
277
|
Cultured human intestinal mast cells express functional IL-3 receptors and respond to IL-3 by enhancing growth and IgE receptor-dependent mediator release.
|
Eur J Immunol
|
2002
|
0.86
|
|
278
|
Increased epithelial permeability is the primary cause for bicarbonate loss in inflamed murine colon.
|
Inflamm Bowel Dis
|
2013
|
0.86
|
|
279
|
Rapamycin delays tumor development in murine livers by inhibiting proliferation of hepatocytes with DNA damage.
|
Hepatology
|
2009
|
0.85
|
|
280
|
Losing balance: cytokine signaling and cell death in the context of hepatocyte injury and hepatic failure.
|
Eur Cytokine Netw
|
2003
|
0.85
|
|
281
|
Interferon-alpha enhances TRAIL-mediated apoptosis by up-regulating caspase-8 transcription in human hepatoma cells.
|
J Hepatol
|
2005
|
0.85
|
|
282
|
HBeAg-positive hepatitis delta: virological patterns and clinical long-term outcome.
|
Liver Int
|
2012
|
0.85
|
|
283
|
Merging models of hepatitis C virus pathogenesis.
|
Semin Liver Dis
|
2005
|
0.85
|
|
284
|
Effect of oral lactulose on clinical and immunohistochemical parameters in patients with inflammatory bowel disease: a pilot study.
|
BMC Gastroenterol
|
2007
|
0.85
|
|
285
|
Fate and function of hepatitis-C-virus-specific T-cells during peginterferon-alpha2b therapy for acute hepatitis C.
|
Antivir Ther
|
2007
|
0.85
|
|
286
|
Increased apoptosis induction in hepatocellular carcinoma by a novel tumor-targeted TRAIL fusion protein combined with bortezomib.
|
Hepatology
|
2013
|
0.85
|
|
287
|
Expression of a cyclin E1 isoform in mice is correlated with the quiescent cell cycle status of hepatocytes in vivo.
|
Hepatology
|
2006
|
0.85
|
|
288
|
beta2-Adrenoceptor-mediated suppression of human intestinal mast cell functions is caused by disruption of filamentous actin dynamics.
|
Eur J Immunol
|
2005
|
0.85
|
|
289
|
Gilbert's syndrome and hyperbilirubinemia in protease inhibitor therapy--an extended haplotype of genetic variants increases risk in indinavir treatment.
|
J Hepatol
|
2009
|
0.85
|
|
290
|
Hepatitis delta and HIV infection.
|
Semin Liver Dis
|
2012
|
0.85
|
|
291
|
No evidence of substantial growth progression or complications of large focal nodular hyperplasia during pregnancy.
|
Scand J Gastroenterol
|
2012
|
0.85
|
|
292
|
Identification and characterization of a functional TATA box polymorphism of the UDP glucuronosyltransferase 1A7 gene.
|
Mol Pharmacol
|
2005
|
0.84
|
|
293
|
p53-dependent antiviral RNA-interference facilitates tumor-selective viral replication.
|
Nucleic Acids Res
|
2009
|
0.84
|
|
294
|
Ectopic expression of murine CD47 minimizes macrophage rejection of human hepatocyte xenografts in immunodeficient mice.
|
Hepatology
|
2012
|
0.84
|
|
295
|
A new side effect of immunosuppression: high incidence of hearing impairment after liver transplantation.
|
Liver Transpl
|
2006
|
0.84
|
|
296
|
Hypercortisolaemia due to ectopic adrenocorticotropic hormone secretion by a nasal paraganglioma: a case report and review of the literature.
|
BMC Res Notes
|
2013
|
0.84
|
|
297
|
Urinary Peptide Analysis Differentiates Pancreatic Cancer From Chronic Pancreatitis.
|
Pancreas
|
2016
|
0.84
|
|
298
|
Isolation of human antigen-specific regulatory T cells with high suppressive function.
|
Eur J Immunol
|
2014
|
0.84
|
|
299
|
Induction of a mature hepatocyte phenotype in adult liver derived progenitor cells by ectopic expression of transcription factors.
|
Stem Cell Res
|
2011
|
0.84
|
|
300
|
Lack of gp130 expression results in more bacterial infection and higher mortality during chronic cholestasis in mice.
|
Hepatology
|
2005
|
0.84
|
|
301
|
SLA/LP/tRNP((Ser)Sec) antigen in autoimmune hepatitis: identification of the native protein in human hepatic cell extract.
|
J Autoimmun
|
2009
|
0.84
|
|
302
|
Downregulation of the NHE3-binding PDZ-adaptor protein PDZK1 expression during cytokine-induced inflammation in interleukin-10-deficient mice.
|
PLoS One
|
2012
|
0.84
|
|
303
|
Kinetics of hepatitis C viral RNA and HCV-antigen during dialysis sessions: evidence for differential viral load reduction on dialysis.
|
J Med Virol
|
2008
|
0.84
|
|
304
|
Selenocysteine, soluble liver antigen/liver-pancreas, and autoimmune hepatitis.
|
Hepatology
|
2007
|
0.84
|
|
305
|
Intrahepatic long-term persistence of parvovirus B19 and its role in chronic viral hepatitis.
|
J Med Virol
|
2009
|
0.84
|
|
306
|
Effect of H. pylori on the expression of TRAIL, FasL and their receptor subtypes in human gastric epithelial cells and their role in apoptosis.
|
Helicobacter
|
2004
|
0.84
|
|
307
|
cAMP-dependent and cholinergic regulation of the electrogenic intestinal/pancreatic Na+/HCO3- cotransporter pNBC1 in human embryonic kidney (HEK293) cells.
|
BMC Cell Biol
|
2008
|
0.84
|
|
308
|
Fighting the bushfire in HCC trials.
|
J Hepatol
|
2011
|
0.84
|
|
309
|
Hepatitis A virus infection suppresses hepatitis C virus replication and may lead to clearance of HCV.
|
J Hepatol
|
2006
|
0.84
|
|
310
|
Biliary cast syndrome post-liver transplantation: risk factors and outcome.
|
Liver Int
|
2013
|
0.84
|
|
311
|
The German network of excellence for viral hepatitis (Hep-Net).
|
Hepatology
|
2003
|
0.83
|
|
312
|
Outcome stagnation of liver transplantation for primary sclerosing cholangitis in the Model for End-Stage Liver Disease era.
|
Langenbecks Arch Surg
|
2014
|
0.83
|
|
313
|
Clinical and prognostic role of plasma coagulation factor XIII activity for bleeding disorders and 6-year survival in patients with chronic liver disease.
|
Liver Int
|
2006
|
0.83
|
|
314
|
Immediate vs. delayed treatment in patients with acute hepatitis C based on IL28B polymorphism: a model-based analysis.
|
J Hepatol
|
2012
|
0.83
|
|
315
|
Differential glucocorticoid effects on repair mechanisms and NF-kappaB activity in the intestinal epithelium.
|
Regul Pept
|
2002
|
0.83
|
|
316
|
Aryl hydrocarbon receptor-mediated regulation of the human estrogen and bile acid UDP-glucuronosyltransferase 1A3 gene.
|
Arch Toxicol
|
2008
|
0.83
|
|
317
|
Natural history: the importance of viral load, liver damage and HCC.
|
Best Pract Res Clin Gastroenterol
|
2008
|
0.83
|
|
318
|
Economic and clinical effects of evaluating rapid viral response to peginterferon alfa-2b plus ribavirin for the initial treatment of chronic hepatitis C.
|
Am J Gastroenterol
|
2003
|
0.82
|
|
319
|
Optimal treatment with boceprevir for chronic HCV infection.
|
Liver Int
|
2013
|
0.82
|
|
320
|
ME3738 protects from concanavalin A-induced liver failure via an IL-6-dependent mechanism.
|
Eur J Immunol
|
2003
|
0.82
|
|
321
|
Cytokine gene polymorphisms and the susceptibility to liver cirrhosis in patients with chronic hepatitis C.
|
Liver Int
|
2003
|
0.82
|
|
322
|
Rapid allelic discrimination by TaqMan PCR for the detection of the Gilbert's syndrome marker UGT1A1*28.
|
J Mol Diagn
|
2008
|
0.82
|
|
323
|
Sustained viral load reduction in treatment-naive HCV genotype 1 infected patients after therapeutic peptide vaccination.
|
Vaccine
|
2012
|
0.82
|
|
324
|
Treatment of hepatitis C in HIV-infected patients: significant progress but not the final step.
|
JAMA
|
2004
|
0.82
|
|
325
|
Lipopolysaccharide-mediated mast cell activation induces IFN-gamma secretion by NK cells.
|
J Immunol
|
2010
|
0.82
|
|
326
|
COACH syndrome associated with multifocal liver tumors.
|
Am J Gastroenterol
|
2002
|
0.82
|
|
327
|
Serum ferritin concentration and transferrin saturation before liver transplantation predict decreased long-term recipient survival.
|
Hepatology
|
2011
|
0.82
|
|
328
|
Plasma P-selectin levels are elevated in patients with chronic liver disease.
|
Blood Coagul Fibrinolysis
|
2003
|
0.82
|
|
329
|
Farnesoid X receptor activation increases cholesteryl ester transfer protein expression in humans and transgenic mice.
|
J Lipid Res
|
2013
|
0.82
|
|
330
|
Biopsy-controlled liver fibrosis staging using the enhanced liver fibrosis (ELF) score compared to transient elastography.
|
PLoS One
|
2012
|
0.82
|
|
331
|
Indications for and outcomes after combined lung and liver transplantation: a single-center experience on 13 consecutive cases.
|
Transplantation
|
2008
|
0.81
|
|
332
|
Targeting of p53-transcriptional dysfunction by conditionally replicating adenovirus is not limited by p53-homologues.
|
Mol Ther
|
2009
|
0.81
|
|
333
|
Peptide-beta2-microglobulin-major histocompatibility complex expressing cells are potent antigen-presenting cells that can generate specific T cells.
|
Immunology
|
2007
|
0.81
|
|
334
|
Effects of azathioprine and its metabolites on repair mechanisms of the intestinal epithelium in vitro.
|
Regul Pept
|
2005
|
0.81
|
|
335
|
Quantification of hepatic thrombopoietin mRNA transcripts in patients with chronic liver diseases shows maintained gene expression in different etiologies of liver cirrhosis.
|
Liver
|
2002
|
0.81
|
|
336
|
Membranous Budd-Chiari syndrome in Caucasians.
|
Scand J Gastroenterol
|
2010
|
0.81
|
|
337
|
Autoimmune hepatitis: the dilemma of rare diseases.
|
Gastroenterology
|
2011
|
0.81
|
|
338
|
A major CYP2D6 autoepitope in autoimmune hepatitis type 2 and chronic hepatitis C is a three-dimensional structure homologous to other cytochrome P450 autoantigens.
|
Autoimmunity
|
2002
|
0.81
|
|
339
|
Hepatitis B surface antigen concentrations in patients with HIV/HBV co-infection.
|
PLoS One
|
2012
|
0.81
|
|
340
|
Plasma amino acids in cirrhosis and after liver transplantation: influence of liver function, hepatic hemodynamics and circulating hormones.
|
Clin Transplant
|
2002
|
0.81
|
|
341
|
Telomeres, telomerase and cancer: an endless search to target the ends.
|
Cell Cycle
|
2004
|
0.81
|
|
342
|
Spontaneous clearance of chronic hepatitis C after liver transplantation: are hepatitis C virus-specific T cell responses the clue?
|
Liver Transpl
|
2008
|
0.81
|
|
343
|
Gender matters: estrogen receptor alpha (ERα) and histone deacetylase (HDAC) 1 and 2 control the gender-specific transcriptional regulation of human uridine diphosphate glucuronosyltransferases genes (UGT1A).
|
J Hepatol
|
2013
|
0.81
|
|
344
|
Endoscopic retrograde cholangiopancreaticography prior to explorative laparotomy avoids unnecessary surgery in patients suspected for biliary atresia.
|
J Hepatol
|
2009
|
0.81
|
|
345
|
Gilbert syndrome redefined: a complex genetic haplotype influences the regulation of glucuronidation.
|
Hepatology
|
2012
|
0.81
|
|
346
|
Improved immune status corresponds with long-term decline of quantitative serum hepatitis B surface antigen in HBV/HIV co-infected patients.
|
Viral Immunol
|
2012
|
0.81
|
|
347
|
High prevalence of hepatitis markers in immigrant populations: a prospective screening approach in a real-world setting.
|
Eur J Gastroenterol Hepatol
|
2014
|
0.80
|
|
348
|
Different kinetics of HBV and HCV during haemodialysis and absence of seronegative viral hepatitis in patients with end-stage renal disease.
|
Nephrol Dial Transplant
|
2011
|
0.80
|
|
349
|
The novel immunosuppressive protein kinase C inhibitor sotrastaurin has no pro-viral effects on the replication cycle of hepatitis B or C virus.
|
PLoS One
|
2011
|
0.80
|
|
350
|
Liver-to-plasma vaniprevir (MK-7009) concentration ratios in HCV-infected patients.
|
Antivir Ther
|
2015
|
0.80
|
|
351
|
Differential serum levels of eosinophilic eotaxins in primary sclerosing cholangitis, primary biliary cirrhosis, and autoimmune hepatitis.
|
J Interferon Cytokine Res
|
2013
|
0.80
|
|
352
|
Adjuvant gemcitabine therapy improves survival in a locally induced, R0-resectable model of metastatic intrahepatic cholangiocarcinoma.
|
Hepatology
|
2013
|
0.80
|
|
353
|
Donor origin of de novo hepatocellular carcinoma in hepatic allografts.
|
Transplantation
|
2003
|
0.80
|
|
354
|
Mycophenolate mofetil in combination with recombinant interferon alfa-2a in interferon-nonresponder patients with chronic hepatitis C.
|
J Hepatol
|
2002
|
0.80
|
|
355
|
The predictive value of core antigen testing for the management of hepatitis C patients receiving pegylated interferon/ribavirin treatment.
|
J Med Virol
|
2004
|
0.80
|
|
356
|
Liver transplantation: A new risk factor for intestinal intussusceptions.
|
Ann Hepatol
|
2011
|
0.80
|
|
357
|
Detection of autoimmune regulator gene mutations in children with type 2 autoimmune hepatitis and extrahepatic immune-mediated diseases.
|
J Pediatr
|
2005
|
0.80
|
|
358
|
Chemokine receptor polymorphisms and GB virus C status in HIV-positive patients.
|
AIDS
|
2002
|
0.80
|
|
359
|
A comparison of the outcome of pregnancies after liver and kidney transplantation.
|
Transplantation
|
2013
|
0.80
|
|
360
|
Polyethylene glycol-interferon: current status in hepatitis C virus therapy.
|
J Gastroenterol Hepatol
|
2002
|
0.80
|
|
361
|
Autoimmune hepatitis and overlap syndromes.
|
J Gastroenterol Hepatol
|
2002
|
0.79
|
|
362
|
Activation of nuclear factor E2-related factor 2 in hereditary tyrosinemia type 1 and its role in survival and tumor development.
|
Hepatology
|
2008
|
0.79
|
|
363
|
Treatment of autoimmune hepatitis.
|
Semin Liver Dis
|
2009
|
0.79
|
|
364
|
Prevalence of alpha-fodrin antibodies in patients with chronic hepatitis C infection and Sjögren syndrome.
|
Scand J Gastroenterol
|
2009
|
0.79
|
|
365
|
A rare cause of nonalcoholic fatty liver disease.
|
Ann Intern Med
|
2006
|
0.79
|
|
366
|
Cost-effectiveness of truncated therapy for hepatitis C based on rapid virologic response.
|
Value Health
|
2012
|
0.79
|
|
367
|
Characterization of the inhibition of hepatitis C virus entry by in vitro-generated and patient-derived oxidized low-density lipoprotein.
|
Hepatology
|
2013
|
0.79
|
|
368
|
Contrasting effects of telomere shortening on organ homeostasis, tumor suppression, and survival during chronic liver damage.
|
Oncogene
|
2005
|
0.79
|
|
369
|
Present and future therapy for hepatitis C virus.
|
Expert Rev Anti Infect Ther
|
2006
|
0.79
|
|
370
|
Hepatocellular carcinoma and octreotide: treatment results in prospectively assigned patients with advanced tumor and cirrhosis stage.
|
J Gastroenterol Hepatol
|
2005
|
0.79
|
|
371
|
Kir4.1 channel expression is essential for parietal cell control of acid secretion.
|
J Biol Chem
|
2011
|
0.79
|
|
372
|
Gilbert's syndrome and antiviral therapy of hepatitis C.
|
Ann Hepatol
|
2009
|
0.79
|
|
373
|
Peptidases released by necrotic cells control CD8+ T cell cross-priming.
|
J Clin Invest
|
2013
|
0.79
|
|
374
|
Alterations in glucose metabolism associated with liver cirrhosis persist in the clinically stable long-term course after liver transplantation.
|
Liver Transpl
|
2004
|
0.79
|
|
375
|
Cytoprotective effects of acidosis via heat shock protein HSP27 against the anticancer drug doxorubicin.
|
Cell Mol Life Sci
|
2010
|
0.79
|
|
376
|
Hepatocytes that express variants of cyclophilin A are resistant to HCV infection and replication.
|
Gastroenterology
|
2012
|
0.79
|
|
377
|
Rapid early HDV RNA decline in the peripheral blood but prolonged intrahepatic hepatitis delta antigen persistence after liver transplantation.
|
J Hepatol
|
2011
|
0.79
|
|
378
|
Longer survival of liver transplant recipients with hepatitis virus coinfections.
|
Clin Transplant
|
2007
|
0.79
|
|
379
|
Characterization of a lipoyl domain-independent B-cell autoepitope on the human branched-chain acyltransferase in primary biliary cirrhosis and overlap syndrome with autoimmune hepatitis.
|
Clin Dev Immunol
|
2004
|
0.78
|
|
380
|
Recurrence of Budd-Chiari syndrome after liver transplantation in paroxysmal nocturnal hemoglobinuria.
|
Transpl Int
|
2003
|
0.78
|
|
381
|
Sustained HCV-RNA response and hepatitis Bs seroconversion after individualized antiviral therapy with pegylated interferon alpha plus ribavirin and active vaccination in a hepatitis C virus/hepatitis B virus-coinfected patient.
|
Eur J Gastroenterol Hepatol
|
2007
|
0.78
|
|
382
|
Autoimmunity and hepatitis C.
|
Autoimmun Rev
|
2003
|
0.78
|
|
383
|
Therapy of autoimmune hepatitis.
|
Best Pract Res Clin Gastroenterol
|
2011
|
0.78
|
|
384
|
Changing faces-natural course and treatment of hepatitis C after liver transplantation.
|
J Hepatol
|
2004
|
0.78
|
|
385
|
Primary sterile necrotic cells fail to cross-prime CD8(+) T cells.
|
Oncoimmunology
|
2012
|
0.78
|
|
386
|
Autoimmunity and viruses.
|
Clin Liver Dis
|
2002
|
0.78
|
|
387
|
HBsAg level at time of liver transplantation determines HBsAg decrease and anti-HBs increase and affects HBV DNA decrease during early immunoglobulin administration.
|
J Hepatol
|
2007
|
0.78
|
|
388
|
Hepatitis E Virus Seroprevalence Rate in HIV-Infected Patients in Germany: A Comparison of Two Commercial Assays.
|
Intervirology
|
2015
|
0.77
|
|
389
|
Autoimmune hepatitis in the Alaska Native population: autoantibody profile and HLA associations.
|
Liver Int
|
2013
|
0.77
|
|
390
|
High intrahepatic HHV-6 virus loads but neither CMV nor EBV are associated with decreased graft survival after diagnosis of graft hepatitis.
|
J Hepatol
|
2012
|
0.77
|
|
391
|
PCR-based quantification of amplified RNA from laser microdissected mouse liver samples.
|
Exp Mol Pathol
|
2003
|
0.77
|
|
392
|
Calprotectin in bile: a disease severity marker in patients with primary sclerosing cholangitis.
|
J Clin Gastroenterol
|
2014
|
0.77
|
|
393
|
Autoimmune hepatitis in a murine autoimmune polyendocrine syndrome type 1 model is directed against multiple autoantigens.
|
Hepatology
|
2015
|
0.77
|
|
394
|
Prediction of outcome and selection of the liver transplantat candidate in acute liver failure.
|
Front Physiol
|
2012
|
0.77
|
|
395
|
Tumor-induced CD11b(+) Gr-1(+) myeloid-derived suppressor cells exacerbate immune-mediated hepatitis in mice in a CD40-dependent manner.
|
Eur J Immunol
|
2015
|
0.77
|
|
396
|
The suppressive effect that myriocin has on hepatitis C virus RNA replication is independent of inhibition of serine palmitoyl transferase.
|
J Infect Dis
|
2008
|
0.77
|
|
397
|
Anti-HBc seroconversion after transplantation of anti-HBc positive nonliver organs to anti-HBc negative recipients.
|
Transplantation
|
2006
|
0.77
|
|
398
|
Anti-parietal cell autoantibodies (PCA) in primary biliary cirrhosis: a putative marker for recurrence after orthotopic liver transplantation?
|
Ann Hepatol
|
2010
|
0.77
|
|
399
|
Autoimmune hepatitis in the elderly: what is the difference?
|
J Hepatol
|
2006
|
0.77
|
|
400
|
Intraportal infusion of 99mtechnetium-macro-aggregrated albumin particles and hepatocytes in rabbits: assessment of shunting and portal hemodynamic changes.
|
Transplantation
|
2003
|
0.77
|
|
401
|
Does the presence of adefovir-resistant variants lead to failure of tenofovir monotherapy?
|
J Hepatol
|
2008
|
0.77
|
|
402
|
Genotyping of the UDP-glucuronosyltransferase (UGT) 1A7 gene revisited.
|
Gastroenterology
|
2011
|
0.77
|
|
403
|
Identification of a novel murine pancreatic tumour antigen, which elicits antibody responses in patients with pancreatic carcinoma.
|
Immunology
|
2009
|
0.77
|
|
404
|
Ferritin and liver allocation? Impact on mortality not only on the waiting list but also after orthotopic liver transplantation should be considered.
|
Hepatology
|
2010
|
0.77
|
|
405
|
Hepatic amino-acid metabolism in liver cirrhosis and in the long-term course after liver transplantation.
|
Transpl Int
|
2002
|
0.77
|
|
406
|
A rare manifestation of Behçet's syndrome: immunological correlates and successful treatment of an esophageal ulcer.
|
Dig Dis Sci
|
2003
|
0.76
|
|
407
|
Lamivudine transiently reduces viral load and improves liver function in liver transplant recipients with fibrosing cholestatic hepatitis.
|
Am J Gastroenterol
|
2002
|
0.76
|
|
408
|
[New devices in liver replacement therapy].
|
Med Klin (Munich)
|
2003
|
0.76
|
|
409
|
Screening colonoscopy in liver transplant candidates: risks and findings.
|
Clin Transplant
|
2013
|
0.76
|
|
410
|
Adenosine and IFN-{alpha} synergistically increase IFN-gamma production of human NK cells.
|
J Leukoc Biol
|
2008
|
0.76
|
|
411
|
Regional and transient ischemia/reperfusion injury in the liver improves therapeutic efficacy of allogeneic intraportal hepatocyte transplantation in low-density lipoprotein receptor deficient Watanabe rabbits.
|
J Hepatol
|
2004
|
0.76
|
|
412
|
Autoimmune hepatitis.
|
Curr Gastroenterol Rep
|
2005
|
0.76
|
|
413
|
Transgastrically placed endoscopic vacuum-assisted closure system as an addition to transgastric necrosectomy in necrotizing pancreatitis (with video).
|
Gastrointest Endosc
|
2012
|
0.76
|
|
414
|
A Critical Role for Notch Signaling in the Formation of Cholangiocellular Carcinomas.
|
Cancer Cell
|
2016
|
0.76
|
|
415
|
Republished paper: Managing HBV in patients with impaired immunity.
|
Postgrad Med J
|
2011
|
0.76
|
|
416
|
Antineutrophil cytoplasmic antibodies in bile are associated with disease activity in primary sclerosing cholangitis.
|
Scand J Gastroenterol
|
2013
|
0.76
|
|
417
|
Altered alanine plasma levels despite normalized hepatic alanine extraction in the long-term course after liver transplantation.
|
Transplantation
|
2003
|
0.76
|
|
418
|
BRaf and MEK inhibitors differentially regulate cell fate and microenvironment in human hepatocellular carcinoma.
|
Clin Cancer Res
|
2014
|
0.76
|
|
419
|
Discussion on the association between hepatitis C infection and survival after orthotopic liver transplantation.
|
Gastroenterology
|
2002
|
0.75
|
|
420
|
[Correction of Prof. Dr. U. Leuschner].
|
Z Gastroenterol
|
2013
|
0.75
|
|
421
|
In reply.
|
Dtsch Arztebl Int
|
2014
|
0.75
|
|
422
|
Immunoglobulin G4-associated cholangitis: dominating immunoglobulin G4-positive clones within the B-cell receptor repertoire indicate light at the end of a long tunnel.
|
Hepatology
|
2013
|
0.75
|
|
423
|
Budd-Chiari syndrome after treatment with budesonide in a cirrhotic patient with autoimmune hepatitis.
|
Ann Hepatol
|
2011
|
0.75
|
|
424
|
p18(INK4c) expression in hepatocellular carcinoma.
|
Hepatology
|
2005
|
0.75
|
|
425
|
Can epoetin alfa maintain ribavirin doses in patients with hepatitis C virus on combination therapy?
|
Nat Clin Pract Gastroenterol Hepatol
|
2004
|
0.75
|
|
426
|
Treatment of acute hepatitis C-how to explain the differences?
|
Gastroenterology
|
2006
|
0.75
|
|
427
|
Meganuclease-mediated virus self-cleavage facilitates tumor-specific virus replication.
|
Mol Ther
|
2013
|
0.75
|
|
428
|
Immunology and liver disease/liver and metabolic syndrome. Preface.
|
Dig Dis
|
2010
|
0.75
|
|
429
|
Leptin and insulin response to long-term total parenteral nutrition depends on body fat mass.
|
Clin Nutr
|
2006
|
0.75
|
|
430
|
New approaches and therapeutic modalities for the treatment of patients with chronic hepatitis C.
|
Ann Hepatol
|
2005
|
0.75
|
|
431
|
Hepatic T Cell Tolerance Induction in An Inflammatory Environment.
|
Dig Dis
|
2017
|
0.75
|
|
432
|
Home-based drainage of refractory ascites by a permanent-tunneled peritoneal catheter can safely replace large-volume paracentesis.
|
Eur J Gastroenterol Hepatol
|
2017
|
0.75
|
|
433
|
Acute gastrointestinal bleeding cases presenting to the emergency department are associated with age, sex and seasonal and circadian factors.
|
Eur J Gastroenterol Hepatol
|
2017
|
0.75
|
|
434
|
Treatment of hepatitis C virus-associated inflammatory polyneuropathy with pegylated interferon-alpha and ribavirin.
|
Eur J Gastroenterol Hepatol
|
2007
|
0.75
|
|
435
|
High rate of unperceived hearing loss in patients after liver transplantation.
|
Clin Transplant
|
2012
|
0.75
|
|
436
|
Recurrent acute pancreatitis in a young woman with a history of asymptomatic lipase elevations for several years.
|
Gastroenterology
|
2011
|
0.75
|
|
437
|
|
Z Gastroenterol
|
2017
|
0.75
|
|
438
|
Special issue on the lectures on the 5th International Hannover Conference on Hepatic Encephalopathy. Introduction.
|
Metab Brain Dis
|
2010
|
0.75
|
|
439
|
Microbiological analysis of fluids in postsurgical gastroesophageal intrathoracic leaks obtained by endoscopy: a new way to optimize antibiotic therapy.
|
Digestion
|
2015
|
0.75
|
|
440
|
Gastrointestinal Endoscopy Is Safe in Patients Before and After Lung or Heart Transplantation.
|
Transplantation
|
2015
|
0.75
|
|
441
|
Telomere shortening is associated with reduced duodenal HCOFormula secretory but normal gastric acid secretory capacity in aging mice.
|
Am J Physiol Gastrointest Liver Physiol
|
2012
|
0.75
|
|
442
|
Decrease of CD44-positive cells correlates with tumor response to chemotherapy in patients with gastrointestinal cancer.
|
Anticancer Res
|
2012
|
0.75
|
|
443
|
Perihilar lymph nodes in patients with primary sclerosing cholangitis with and without cholangiocellular carcinoma.
|
Scand J Gastroenterol
|
2008
|
0.75
|
|
444
|
Symptoms of anxiety and depression are frequent in patients with acute hepatitis C and are not associated with disease severity.
|
Eur J Gastroenterol Hepatol
|
2016
|
0.75
|
|
445
|
Autoimmunity and HCV infection in porphyria cutanea tarda: a controlled study.
|
Cell Mol Biol (Noisy-le-grand)
|
2002
|
0.75
|
|
446
|
Procedure-related pulmonary hypertension in patients with hepatocellular carcinoma undergoing percutaneous ethanol injection--role of ethanol, hemolysis, asymmetric dimethylarginine, and the nitric oxide system.
|
Crit Care Med
|
2009
|
0.75
|
|
447
|
Autoimmune liver disease.
|
Best Pract Res Clin Gastroenterol
|
2011
|
0.75
|
|
448
|
[Widespread and mostly unrecognized: chronic hepatitis B: the silent epidemic (interview by Maria Weiss)].
|
MMW Fortschr Med
|
2009
|
0.75
|
|
449
|
Shared regulation of UGT1A7 by hepatocyte nuclear factor (HNF) 1alpha and HNF4alpha.
|
Drug Metab Dispos
|
2010
|
0.75
|
|
450
|
Stability and transmission of hepatitis C virus in different anesthetic agents.
|
Am J Infect Control
|
2013
|
0.75
|
|
451
|
Low Risk of Developing Chronic Hepatitis E in Heart Transplant Recipients: A Prospective 2-Year Follow-Up Study.
|
Intervirology
|
2017
|
0.75
|
|
452
|
Home-based drainage of refractory ascites by a permanent-tunneled peritoneal catheter can safely replace large-volume paracentesis.
|
Eur J Gastroenterol Hepatol
|
2017
|
0.75
|
|
453
|
Comprehensive phenotyping of regulatory T cells after liver transplantation.
|
Liver Transpl
|
2015
|
0.75
|
|
454
|
Seroprevalence of antibodies and antigens against hepatitis A-E viruses in refugees and asylum seekers in Germany in 2015.
|
Eur J Gastroenterol Hepatol
|
2017
|
0.75
|
|
455
|
[Joint opinion of the German Society of Gastroenterology, Digestive and Metabolic Diseases (DGVS) and the German Society for Internal Medicine (DGIM) to Daclatasvir-benefit assessment according to § 35a SGB V the G-BA].
|
Z Gastroenterol
|
2015
|
0.75
|
|
456
|
Mycosis fungoides with involvement of the larynx after liver transplantation in an adult.
|
Am J Gastroenterol
|
2010
|
0.75
|
|
457
|
Fine needle sclerotherapy as a new effective therapeutic approach for nonparasitic splenic cysts: a case series.
|
Dig Liver Dis
|
2013
|
0.75
|
|
458
|
Transition of care between paediatric and adult gastroenterology. Autoimmune hepatitis.
|
Best Pract Res Clin Gastroenterol
|
2003
|
0.75
|
|
459
|
Efficacy and safety of anticoagulation with heparin versus heparin plus epoprostenol in patients undergoing extracorporeal liver support with Prometheus.
|
Artif Organs
|
2009
|
0.75
|
|
460
|
[In Process Citation].
|
Z Gastroenterol
|
2015
|
0.75
|
|
461
|
[Current Guidelines for treatment of hepatitis B. Correct diagnosis is the prerequisite.].
|
Pharm Unserer Zeit
|
2011
|
0.75
|
|
462
|
Unexplained jaundice after squirrel bite. It's not what you look at that matters, it's what you see (H. D. Thoreanu).
|
J Gastrointestin Liver Dis
|
2011
|
0.75
|
|
463
|
[Joint Statement of the German Society of Gastroenterology, Digestive and Metabolic Diseases (DGVS) and the German Society for Internal Medicine (DGIM) to Simeprevir-benefit assessment according to § 35a SGB V the Federal Joint Committee].
|
Z Gastroenterol
|
2014
|
0.75
|
|
464
|
Safety and performance of liver biopsies in liver transplant recipients.
|
Clin Transplant
|
2014
|
0.75
|
|
465
|
Risk of infections during interferon-based treatment in patients with chronic hepatitis C virus infection and advanced hepatic fibrosis.
|
J Gastroenterol Hepatol
|
2015
|
0.75
|
|
466
|
How to interpret borderline HCV antibody test results: a comparative study investigating four different anti-HCV assays.
|
Viral Immunol
|
2014
|
0.75
|
|
467
|
Anti-retroviral drugs do not facilitate hepatitis C virus (HCV) infection in vitro.
|
Antiviral Res
|
2012
|
0.75
|